April 6, 2011 (Chicago, Illinois) — An initial session of pelvic arterial embolization (PAE) is safe and effective in 86.2% of patients with postpartum hemorrhage. Ji Hoon Shin, MD, associate ...

It’s Black Maternal Health Week. Here’s everything you should know to protect yourself and those you love. As a board-certified obstetrician and gynecologist, Kameelah Phillips, MD, knows what it ...

“No woman should fear for her life when giving birth. Effective solutions to tackle postpartum bleeding need to be available and accessible so that all women can experience a safe birth and a healthy ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently granted 510(k) clearance for Jada System, a device its manufacturer said “rapidly controls and ...

The Jada System is comprised of an intrauterine device that utilizes low level vacuum to induce normal contraction of the uterus. The Food and Drug Administration has cleared updates to the Jada ® ...

Maternal morbidity increased by 30.4% in preterm vs. term births. The most prevalent complications for both term and preterm births were postpartum hemorrhage, use of a uterotonic agent and ...

Kelsey Mayo, CEO of Armor Medical, received the grand prize in MedTech Innovator’s pitch competition for a wearable ...

Postpartum hemorrhage (PPH) is the leading cause of maternal deaths worldwide, particularly in the least developed and developing countries. Of the 14 million female patients affected each year, ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

MENLO PARK, Calif.--(BUSINESS WIRE)--Alydia Health, a clinical-stage medical device company dedicated to making childbirth safer for all mothers, today announced that the company has completed ...